DFM Platform
DFM Funding Monitor

EU dual-use research funding — who's getting it

Horizon Europe dual-use & security-relevant research grants — EC contribution, coordinator and beneficiaries.

Updated monthly from CORDIS open data · last refresh 2026-08-01.

Research grants

2831

Updated

2026-08-01
About the data

Source: CORDIS (official EU open data), Horizon Europe civil R&I — the dual-use / security-relevant subset (Cluster 3 Civil Security, defence-relevant keywords, plus EIC deep-tech and space). EDF military R&D is a separate instrument and is not included. Monetary figures are the EC contribution in EUR as published by the Commission.

Get the EU Defence Funding Calendar — free

The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.

We store your email to send the calendar and the weekly DFM Analysis briefing. Nothing else. Unsubscribe anytime.

Or browse all open defence & dual-use calls on the funding calendar →

ProjectCoordinatorProgrammeEC contributionBenef.CORDIS
The first universal and price-neutral insulin penbroad
GO-Pen · 2023-03-01–2025-08-31
GO-PEN APS HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
ContraBand: the only heart failure medical device that is placedbroad
Contraband · 2022-12-01–2024-11-30
RESTORE MEDICAL LTD HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
Disrupting the cooling and heating industry: a revolutionary grebroad
Magnetocaloric heating and cooling · 2023-12-01–2026-11-30
MAGNETO BV HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 1 CORDIS →
Enabling efficient computation on fault tolerant quantum computebroad
COMFTQUA · 2023-07-01–2025-12-31
BEIT SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 1 CORDIS →
Adpative DBSbroad
alphadbs · 2023-03-01–2025-02-28
NEWRONIKA SPA HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
First economically-viable process for phosphate recoverybroad
SusPhos · 2023-03-01–2025-02-28
NEPTUNA VENTURES BV HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
Commercialising a smart cardiac implant platform for the treatmebroad
ALLIANCE · 2023-06-01–2025-06-30
AURIGEN MEDICAL LIMITED HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
Sonophoresis smartpatch for pain-free, controllable, and wearablbroad
SONOPHORESIS SMARTPATCH · 2023-08-01–2026-05-31
MEDICSENSORS SL HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 1 CORDIS →
Commercialisation and scale up of a Vaginal Microbiome Screeningbroad
VMS - Vaginal Microbiome Screening · 2023-07-01–2025-06-30
TAMPONENI INOVATSII OOD HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 1 CORDIS →
The first broad-spectrum treatment against pandemic-prone flavivbroad
ATLAS · 2023-03-01–2026-08-31
PROTINHI BV HORIZON-EIC-2022-ACCELERATOR-01 €2,499,999 1 CORDIS →
First-in-class anti-PVR mAb NTX1088 - a novel oncology drug thatbroad
NTX1088 · 2024-08-01–2028-01-31
NECTIN THERAPEUTICS LTD HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 1 CORDIS →
Macrophage-based immunotherapy of platinum-resistant ovarian canbroad
MACOV · 2022-11-01–2026-04-30
CELLIS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA HORIZON-EIC-2022-TRANSITION-01 €2,499,999 1 CORDIS →
Hybrid Spintronic Synapses for Neuromorphic Computingbroad
SPIN-ION · 2023-05-01–2025-10-31
SPIN-ION TECHNOLOGIES HORIZON-EIC-2022-TRANSITION-01 €2,499,999 1 CORDIS →
SpiNNaker on the Edgebroad
SPINNODE · 2023-05-01–2025-09-30
SPINNCLOUD SYSTEMS GMBH HORIZON-EIC-2022-TRANSITION-01 €2,499,999 1 CORDIS →
Targeting OGG1 in Idiopathic Pulmonary Fibrosisbroad
TOPFIBRO · 2023-05-01–2026-08-31
OXCIA AB HORIZON-EIC-2022-TRANSITION-01 €2,499,999 1 CORDIS →
Innovative Photoactivated Ruthenium Chemotherapy to treat eye cabroad
PACT4EYE · 2023-11-01–2026-10-31
UNIVERSITEIT LEIDEN HORIZON-EIC-2023-TRANSITION-01 €2,499,999 4 CORDIS →
Universal frequency-comb platform for datacenter communicationsbroad
UNICO · 2023-11-01–2027-01-31
INNOLUME GMBH HORIZON-EIC-2023-TRANSITION-01 €2,499,999 3 CORDIS →
Scalable Hardware for Large-Scale Quantum Computingbroad
SCALLOP · 2023-09-01–2026-08-31
SEMIQON TECHNOLOGIES OY HORIZON-EIC-2023-TRANSITION-01 €2,499,999 2 CORDIS →
Making Driving Safer with Augmented realitybroad
Rocksolid AR · 2024-06-01–2025-12-31
BASEMARK OY HORIZON-EIC-2023-ACCELERATOR-01 €2,499,999 2 CORDIS →
AUTOMATED CLINICAL PLATFORM FOR PERSONALIZED ANTIBIOTHERAPY IN Cbroad
ACU-SERS · 2024-05-01–2027-04-30
DANMARKS TEKNISKE UNIVERSITET HORIZON-EIC-2023-TRANSITION-01 €2,499,998 1 CORDIS →
Brain-inspired Computing for Next Generation Generative Artificibroad
SpiNNext · 2025-12-01–2027-11-30
SPINNCLOUD SYSTEMS GMBH HORIZON-EIC-2025-ACCELERATOR-02 €2,499,998 1 CORDIS →
Superconductor-Based Readiness Enhanced Magnetoplasmadynamic Elebroad
SUPREME · 2023-06-01–2025-11-30
UNIVERSITY OF STUTTGART HORIZON-EIC-2022-TRANSITION-01 €2,499,996 5 CORDIS →
Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) tbroad
SOMIT-CD · 2022-09-01–2025-03-31
ALLERO THERAPEUTICS BV HORIZON-EIC-2021-ACCELERATOROPEN-01 €2,499,993 1 CORDIS →
A novel Renewable Energy Storage System tailored for Offshore Apbroad
FLASC HPES · 2025-01-01–2026-12-31
FLASC BV HORIZON-EIC-2023-ACCELERATOR-01 €2,499,991 1 CORDIS →
Next-Gen NMR Prediction and Analysis: A Cutting-Edge Tool for Hibroad
HQS-NextNMR · 2025-03-01–2027-02-28
HQS QUANTUM SIMULATIONS GMBH HORIZON-EIC-2024-TRANSITION-01 €2,499,991 1 CORDIS →
Dencatistat, a first-in-class, tumour-agnostic, orally availablebroad
STP938 · 2026-06-01–2027-08-31
STEP PHARMA HORIZON-EIC-2025-ACCELERATOR-02 €2,499,990 1 CORDIS →
Unlocking serial Aluminium Additive Manufacturing with Molten Mebroad
MMD · 2024-03-01–2026-06-30
VALCUN BV HORIZON-EIC-2023-ACCELERATOR-01 €2,499,988 1 CORDIS →
Near natural hearing restoration through waveguide-based opticalbroad
OptoWavePro · 2024-04-01–2027-03-31
UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS HORIZON-EIC-2023-TRANSITION-01 €2,499,984 5 CORDIS →
Broadband Infrared Emitters for Generalized High-Tech IR Sensingbroad
BRIGHTIR · 2026-05-01–2028-04-30
4K-MEMS SA HORIZON-EIC-2025-TRANSITIONOPEN €2,499,978 2 CORDIS →
Integrated Sensor Platform for Real-time Monitoring of Key Procebroad
ArgusEye · 2026-06-01–2028-05-31
ArgusEye AB HORIZON-EIC-2025-ACCELERATOR-02 €2,499,976 1 CORDIS →
Laser digital transfer of 2D materials enabled photonics: from tbroad
L2D2 · 2022-10-01–2025-12-31
ETHNICON METSOVION POLYTECHNION HORIZON-EIC-2021-TRANSITIONOPEN-01 €2,499,975 5 CORDIS →
Miniaturised MEMS-based spectrometers for the Mid-Infrared spectbroad
MIMIR · 2026-05-01–2029-04-30
CY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD HORIZON-EIC-2025-TRANSITIONOPEN €2,499,969 5 CORDIS →
Transcription Factor Gene Therapy for Bradyarrhythmiasbroad
TRACTION · 2023-01-01–2025-12-31
PACINGCURE B.V. HORIZON-EIC-2022-TRANSITION-01 €2,499,968 2 CORDIS →
Democratizing Cryogenic Measurements for the Quantum Ecosystembroad
CRYOFAST · 2024-11-01–2026-10-31
KIUTRA GMBH HORIZON-EIC-2024-ACCELERATOR-02 €2,499,962 1 CORDIS →
LIACFLASH: a life changing IOeRT technology for oncology carebroad
LIAC FLASH · 2022-12-01–2025-05-31
S.I.T. - SORDINA IORT TECHNOLOGIES SPA HORIZON-EIC-2022-ACCELERATOR-01 €2,499,962 1 CORDIS →
Real-time nutrient sensing for mapping fertilizer needsbroad
LiveSen-MAP · 2023-06-01–2026-05-31
TECHNISCHE UNIVERSITAET MUENCHEN HORIZON-EIC-2022-TRANSITION-01 €2,499,955 1 CORDIS →
Bringing Lithium-Ion Battery Waste tozerobroad
ToZero · 2024-12-01–2026-11-30
TOZERO GMBH HORIZON-EIC-2024-ACCELERATOR-02 €2,499,952 1 CORDIS →
Innovative macrophage therapies to transform treatment paradigm broad
STEMPhage · 2026-05-01–2028-10-31
TECHNISCHE UNIVERSITAET DRESDEN HORIZON-EIC-2025-TRANSITIONOPEN €2,499,935 1 CORDIS →
Radically New Cancer Therapy Based on Advances in Nanotechnologybroad
ScanNanoTreat · 2025-06-01–2028-05-31
UNIVERSITE LYON 1 CLAUDE BERNARD HORIZON-EIC-2024-TRANSITION-01 €2,499,911 6 CORDIS →
Cultivating hope one star sperm at a timebroad
Spermotile · 2025-04-01–2027-09-30
UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET HORIZON-EIC-2024-TRANSITION-01 €2,499,906 1 CORDIS →
FlowAssist Pouch will help to improve the skin condition of ostobroad
FlowAssist Pouch · 2023-01-01–2024-12-31
OSTOFORM LIMITED HORIZON-EIC-2022-ACCELERATOR-01 €2,499,901 1 CORDIS →
Highly efficient, heavy metal-free color conversion ink technolobroad
QustomDot · 2024-03-01–2026-08-31
QUSTOMDOT HORIZON-EIC-2023-ACCELERATOR-01 €2,499,894 1 CORDIS →
REplaceable Chiplet LInks for Quantum Scalingbroad
RE-CLIQS · 2026-04-01–2028-03-31
QUANTWARE B.V. HORIZON-EIC-2025-TRANSITIONOPEN €2,499,888 1 CORDIS →
Foundation Model-Based Biomarker Platform for Radiology and Clinbroad
FoundRa · 2024-11-01–2026-10-31
RAIDIUM HORIZON-EIC-2024-ACCELERATOR-02 €2,499,875 1 CORDIS →
Magneto eTrieve thrombectomy system EIC funding applicationbroad
MGN-2024-10 · 2025-07-01–2027-06-30
MAGNETO THROMBECTOMY SOLUTIONS LTD HORIZON-EIC-2024-ACCELERATOR-02 €2,499,875 1 CORDIS →
A First-in-Class MCL-1 degrader to promote apoptosis in therapy-broad
CT-03 · 2026-01-01–2027-12-31
Captor Therapeutics Spolka Akcyjna HORIZON-EIC-2024-ACCELERATOR-02 €2,499,875 1 CORDIS →
Scaling Up Biostimulant Technology for Agriculture Resilient to broad
SUBTARC · 2025-10-01–2027-09-30
AGROBIOMICS APS HORIZON-EIC-2025-ACCELERATOR-02 €2,499,875 1 CORDIS →
Manufacturing quantum advantage via scalable germanium quantum pbroad
DISQO · 2025-12-01–2027-11-30
Groove Quantum B.V. HORIZON-EIC-2025-ACCELERATOR-02 €2,499,875 1 CORDIS →
Life Saving Technology for Thoracic Trauma Treatment and Post Opbroad
C-LANT Drainage Port · 2023-03-01–2025-11-30
VIGOR MEDICAL TECHNOLOGIES LTD HORIZON-EIC-2022-ACCELERATOR-01 €2,499,875 1 CORDIS →
Nobula – Breaking the glass ceiling in Additive Manufacturing thbroad
NOBULA · 2023-08-01–2026-04-30
NOBULA3D AB HORIZON-EIC-2023-ACCELERATOR-01 €2,499,875 1 CORDIS →

‹ PrevPage 41 of 57Next ›

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.

DFM Analysis, our free weekly newsletter, tracks the EU defence-funding programmes, calls and decisions behind this page. Subscribe free →